OR Royalties Inc. $OR Stock Holdings Lifted by Y Intercept Hong Kong Ltd

Y Intercept Hong Kong Ltd grew its position in OR Royalties Inc. (NYSE:ORFree Report) by 145.7% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 157,044 shares of the basic materials company’s stock after purchasing an additional 93,128 shares during the period. Y Intercept Hong Kong Ltd’s holdings in OR Royalties were worth $5,971,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the company. Linden Thomas Advisory Services LLC lifted its holdings in shares of OR Royalties by 4.1% during the 4th quarter. Linden Thomas Advisory Services LLC now owns 6,254 shares of the basic materials company’s stock valued at $221,000 after buying an additional 249 shares during the last quarter. Wells Fargo & Company MN increased its holdings in OR Royalties by 6.2% in the fourth quarter. Wells Fargo & Company MN now owns 5,901 shares of the basic materials company’s stock worth $209,000 after buying an additional 346 shares during the last quarter. Allworth Financial LP increased its holdings in OR Royalties by 20.0% in the fourth quarter. Allworth Financial LP now owns 2,305 shares of the basic materials company’s stock worth $82,000 after buying an additional 384 shares during the last quarter. Cetera Investment Advisers raised its position in OR Royalties by 3.5% during the second quarter. Cetera Investment Advisers now owns 13,147 shares of the basic materials company’s stock valued at $337,000 after acquiring an additional 440 shares in the last quarter. Finally, FIL Ltd bought a new position in OR Royalties during the fourth quarter valued at approximately $29,000. 68.52% of the stock is owned by hedge funds and other institutional investors.

OR Royalties Stock Performance

Shares of OR stock opened at $31.31 on Friday. The stock’s 50 day simple moving average is $35.50 and its 200 day simple moving average is $38.58. OR Royalties Inc. has a twelve month low of $25.30 and a twelve month high of $48.06. The company has a market capitalization of $5.87 billion, a price-to-earnings ratio of 23.36 and a beta of 0.74.

OR Royalties (NYSE:ORGet Free Report) last announced its earnings results on Wednesday, May 6th. The basic materials company reported $0.40 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.34 by $0.06. OR Royalties had a return on equity of 15.10% and a net margin of 78.09%.The firm had revenue of $102.83 million during the quarter, compared to analysts’ expectations of $103.27 million. On average, analysts forecast that OR Royalties Inc. will post 1.4 EPS for the current fiscal year.

OR Royalties Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 15th. Stockholders of record on Tuesday, June 30th will be paid a $0.065 dividend. The ex-dividend date is Tuesday, June 30th. This is a positive change from OR Royalties’s previous quarterly dividend of $0.06. This represents a $0.26 dividend on an annualized basis and a dividend yield of 0.8%. OR Royalties’s dividend payout ratio is presently 19.40%.

Analyst Upgrades and Downgrades

OR has been the subject of a number of analyst reports. Zacks Research cut shares of OR Royalties from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, March 31st. Royal Bank Of Canada restated an “outperform” rating and set a $56.00 price target on shares of OR Royalties in a report on Friday, April 10th. Weiss Ratings lowered shares of OR Royalties from a “buy (b)” rating to a “buy (b-)” rating in a research note on Thursday, June 4th. Finally, Wall Street Zen cut shares of OR Royalties from a “buy” rating to a “hold” rating in a report on Saturday, June 6th. One analyst has rated the stock with a Strong Buy rating, four have given a Buy rating and four have issued a Hold rating to the company. According to data from MarketBeat.com, OR Royalties currently has a consensus rating of “Moderate Buy” and an average target price of $46.50.

Get Our Latest Stock Report on OR

OR Royalties Profile

(Free Report)

OR Royalties PLC (NYSE: OR) is a closed-ended investment company that specializes in acquiring and managing royalty interests in life science and pharmaceutical products. The company provides capital to biotechnology, specialty pharmaceutical and medical device companies in exchange for a share of future sales revenues. By focusing on royalties secured against marketed products, OR Royalties aims to deliver income and growth potential while minimizing the development and commercialization risks typically associated with direct equity stakes.

The company’s core activities include sourcing royalty transactions, structuring bespoke financing solutions and actively monitoring a diversified portfolio of assets.

Recommended Stories

Want to see what other hedge funds are holding OR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for OR Royalties Inc. (NYSE:ORFree Report).

Institutional Ownership by Quarter for OR Royalties (NYSE:OR)

Receive News & Ratings for OR Royalties Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OR Royalties and related companies with MarketBeat.com's FREE daily email newsletter.